跳至主要内容
临床试验/IRCT20170315033086N5
IRCT20170315033086N5已完成2 期

Investigation of Anti-inflammatory Effects of strowell capsules on Plasma Inflammatory Factors in Ischemic Stroke Patients: A Randomized, Double-blind Placebo-controlled Trial

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 80 years(—)
性别
All

入选标准

  • Diagnosis, based on neurological diagnostic signs and confirmed by Magnetic Resonance Imaging (MRI)
  • National Institutes of Health Stroke Scale (NIHSS) should be in 4 - 20 range at the time of admission.
  • Body mass index (BMI) should be in 20-25 range
  • No inflammatory diseases

排除标准

  • Hemorrhagic stroke
  • transient ischemic attack (TIA)
  • History of gastrointestinal bleeding
  • History of sensitivity to NSIADs
  • Previous stroke
  • Myocardial infarction within the previous 48 hours
  • Kidney and liver failure
  • Immunosuppressive medications
  • Stroke patients who have received tissue plasminogen activator (tPA).
  • Rheumatoid and autoimmune diseases
  • Malignancies
  • Pregnancy or lactation

研究者

相似试验